Neuroone Medical Technologies (NMTC) Change in Receivables (2020 - 2026)

Neuroone Medical Technologies has disclosed Change in Receivables across 7 years of filings, most recently posting -$764484.0 for Q1 2026.

• Quarterly Change in Receivables rose 62.71% year-over-year to -$764484.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (up 766.47% YoY) and the FY2025 annual result came in at $1.1 million, up 516.05% from the prior year.
• Change in Receivables declined to -$764484.0 in Q1 2026, from $1.4 million in the prior quarter.
• Across five years, Change in Receivables topped out at $2.2 million in Q4 2024 and bottomed at -$2.1 million in Q1 2025.
• The 5-year median for Change in Receivables is $12098.0 (2022), against an average of $117047.2.
• Year-over-year, Change in Receivables surged 892.25% in 2023 and plunged 16849.45% in 2025.
• Neuroone Medical Technologies' Change in Receivables stood at $62082.0 in 2022, then jumped by 775.29% to $543399.0 in 2023, then soared by 303.44% to $2.2 million in 2024, then tumbled by 36.27% to $1.4 million in 2025, then slumped by 154.72% to -$764484.0 in 2026.
• According to Business Quant data, Change in Receivables over the past three periods registered -$764484.0, $1.4 million, and $1.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.